- Home
- STRO vs EDAP Comparison
STRO vs EDAP Comparison
Compare STRO & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- EDAP
- Stock Information
- Founded
- STRO 2003
- EDAP 1979
- Country
- STRO United States
- EDAP France
- Employees
- STRO N/A
- EDAP N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- EDAP Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- STRO Health Care
- EDAP Health Care
- Exchange
- STRO Nasdaq
- EDAP Nasdaq
- Market Cap
- STRO 50.0M
- EDAP 53.8M
- IPO Year
- STRO 2018
- EDAP 1997
- Fundamental
- Price
- STRO $0.87
- EDAP $2.22
- Analyst Decision
- STRO Hold
- EDAP Buy
- Analyst Count
- STRO 8
- EDAP 3
- Target Price
- STRO $6.14
- EDAP $8.50
- AVG Volume (30 Days)
- STRO 2.3M
- EDAP 77.7K
- Earning Date
- STRO 05-08-2025
- EDAP 05-15-2025
- Dividend Yield
- STRO N/A
- EDAP N/A
- EPS Growth
- STRO N/A
- EDAP N/A
- EPS
- STRO N/A
- EDAP N/A
- Revenue
- STRO $62,043,000.00
- EDAP $66,378,507.00
- Revenue This Year
- STRO N/A
- EDAP $0.74
- Revenue Next Year
- STRO $1.29
- EDAP $0.37
- P/E Ratio
- STRO N/A
- EDAP N/A
- Revenue Growth
- STRO N/A
- EDAP 6.11
- 52 Week Low
- STRO $0.52
- EDAP $1.26
- 52 Week High
- STRO $5.17
- EDAP $7.36
- Technical
- Relative Strength Index (RSI)
- STRO 48.53
- EDAP 61.30
- Support Level
- STRO $0.80
- EDAP $2.02
- Resistance Level
- STRO $1.11
- EDAP $2.25
- Average True Range (ATR)
- STRO 0.18
- EDAP 0.18
- MACD
- STRO 0.02
- EDAP 0.06
- Stochastic Oscillator
- STRO 41.53
- EDAP 86.87
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About EDAP EDAP TMS S.A.
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.